2nd Circuit: Shareholders’ COVID-19 Vaccine Misstatements Suit Properly Dismissed
NEW YORK — AstraZeneca PLC shareholders who accused the company and executives of making material misstatements regarding testing of a COVID-19 vaccine failed to “adequately [plead] falsity or facts fiving rise...To view the full article, register now.
Already a subscriber? Click here to view full article